Soru

Zorluk: OrtaEndocrine and Metabolic Mechanisms

A 68-year-old woman with a history of stage 4 chronic kidney disease presents to the clinic for a routine follow-up. Laboratory evaluation reveals a serum calcium level of 7.8 mg/dL and an elevated intact parathyroid hormone level. The physician notes that her hypocalcemia is primarily driven by the loss of functional renal parenchyma, which impairs a critical step in a major endocrine pathway. To review the pathophysiology of her condition, arrange the following biochemical and cellular events involved in the synthesis and mechanism of action of the deficient hormone in the correct chronological sequence, beginning with the initial precursor event.

  1. 1Photochemical cleavage of the B-ring of 7-dehydrocholesterol
  2. 2Cytochrome P450-mediated 25-hydroxylation in hepatocytes
  3. 3Parathyroid hormone-stimulated 1-alpha-hydroxylation
  4. 4Heterodimerization of the bound ligand-receptor complex with the retinoid X receptor
  5. 5Upregulation of calbindin-D9k transcription in enterocytes

Cevap

The correct sequence begins with the photochemical cleavage of 7-dehydrocholesterol in the skin, followed by hepatic 25-hydroxylation, then renal 1-alpha-hydroxylation, followed by intracellular heterodimerization with the retinoid X receptor, and finally the upregulation of calbindin-D9k transcription in enterocytes.
The correct sequence accurately reflects the biological pathway of vitamin D. It begins in the skin with the UV-mediated formation of cholecalciferol from 7-dehydrocholesterol. This is followed by hepatic 25-hydroxylation to calcidiol. The rate-limiting and strictly regulated step, 1-alpha-hydroxylation, occurs in the renal proximal tubule to form active calcitriol. Once secreted into the circulation, calcitriol enters target cells (such as enterocytes) to bind the intracellular Vitamin D Receptor (VDR). The VDR-ligand complex heterodimerizes with the Retinoid X Receptor (RXR), binds to DNA response elements, and upregulates the transcription of calcium-binding proteins such as calbindin, which are necessary for the intestinal absorption of calcium.

Adım Adım Çözüm

1
Identify the deficient hormone based on the clinical presentation.
The patient has calcitriol (1,25-dihydroxycholecalciferol) deficiency due to advanced chronic kidney disease.
Loss of functioning nephrons reduces 1-alpha-hydroxylase activity, preventing the final activation step of vitamin D and leading to hypocalcemia and secondary hyperparathyroidism.
2
Trace the physiological synthesis of the hormone.
Synthesis begins in the skin with UV light, followed by liver 25-hydroxylation, and finishes with kidney 1-alpha-hydroxylation.
This establishes the first three steps in the systemic biochemical pathway of vitamin D.
3
Determine the cellular mechanism of action of the active hormone in target tissues.
Calcitriol binds to the intracellular VDR, heterodimerizes with RXR, and alters gene expression to produce proteins like calbindin.
This establishes the final two sequential cellular steps that result in the physiological effect (increased calcium absorption).

Anahtar Kavram

Vitamin D synthesis and intracellular mechanism of action
Bu soruyu puanla